brexit-istock-537519806_andrewlinscott
andrewlinscott / iStockphoto.com
16 August 2019Big PharmaSaman Javed

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

Several pharma bodies have signed non-disclosure agreements (NDAs) which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
8 July 2019   The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019   Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

Europe
8 July 2019   The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019   Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

Europe
8 July 2019   The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
Big Pharma
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.
Big Pharma
3 September 2019   Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.